Delivery Order SPE2DR25D3304-SPE2DR26F48B9
- Not listed
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Carbamazepine ER 100 mg tablets (100-count units) with a ceiling value of $1,035.41. The order, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, with performance of work conducted...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.22 to AmerisourceBergen Drug Corp for Carbamazepine ER 200 mg tablets (100-count packages) with a completion deadline of December 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Carbamazepine ER 400 mg tablets (100-count units) with a ceiling value of $1,569.20. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion on December 11, 2025, with performance to be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,239.75 for Carbamazepine ER 200 mg tablets (100-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The place of performance is the contractor's corporate office in...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Carbamazepine ER 400 mg tablets (100-count units) valued at $1,202.14, with an ultimate completion date of December 10, 2025. This award represents a non-competitive, non-set-aside procurement executed on December 9, 2025, with performance to be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. Carbamazepine is an anticonvulsant medication commonly prescribed for...
- The Defense Logistics Agency awarded a delivery order valued at $1,587.45 to AmerisourceBergen Drug Corp for Carbamazepine 100 mg chewable tablets in quantities of 500, with an ultimate completion date of November 18, 2025. The contract was awarded on a firm fixed-price basis without set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,074.80 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Carbamazepine ER 400 mg tablets in quantities of 100 units. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the qualified vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. As a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Carbamazepine ER 400 mg tablets (100-count units) with a ceiling value of $1,286.47. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The contract is scheduled for ultimate completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,903.33 firm fixed-price delivery order is for the supply of 4,566,709,109 units of Carbamazepine ER 200 mg capsules, a medication used to treat seizures, nerve pain, and bipolar disorder. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Carbamazepine ER 400 mg tablets (100-count units) with a ceiling value of $1,242.64. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F48B9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carbamazepine ER 100 mg capsules (120-count) with a ceiling value of $1,591.22. The contract is a firm fixed price delivery order with an ultimate completion date of December 19, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Carbamazepine, an anticonvulsant and mood-stabilizing medication, falls within the neurological treatment category that comprises a significant portion of the company's federal medical supply portfolio delivered to entities including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/17/25 |